Walgreens Boots Alliance Inc (NASDAQ:WBA) Announces Quarterly Dividend of $0.46

Walgreens Boots Alliance Inc (NASDAQ:WBA) announced a quarterly dividend on Wednesday, July 10th, Zacks reports. Shareholders of record on Tuesday, August 20th will be given a dividend of 0.458 per share by the pharmacy operator on Thursday, September 12th. This represents a $1.83 annualized dividend and a yield of 3.29%. The ex-dividend date of this dividend is Monday, August 19th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44.

Walgreens Boots Alliance has increased its dividend by an average of 6.4% per year over the last three years and has raised its dividend every year for the last 43 years. Walgreens Boots Alliance has a dividend payout ratio of 29.4% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Walgreens Boots Alliance to earn $6.00 per share next year, which means the company should continue to be able to cover its $1.76 annual dividend with an expected future payout ratio of 29.3%.

Walgreens Boots Alliance stock opened at $55.62 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. The firm has a market capitalization of $50.23 billion, a price-to-earnings ratio of 9.24, a price-to-earnings-growth ratio of 1.34 and a beta of 0.82. Walgreens Boots Alliance has a fifty-two week low of $49.31 and a fifty-two week high of $86.31. The firm has a fifty day moving average price of $52.80.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.42 by $0.05. The company had revenue of $34.59 billion for the quarter, compared to analyst estimates of $34.52 billion. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. Walgreens Boots Alliance’s revenue was up .7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.53 earnings per share. On average, equities research analysts anticipate that Walgreens Boots Alliance will post 5.99 earnings per share for the current fiscal year.

In related news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $53.05, for a total transaction of $1,061,000.00. Following the transaction, the chief accounting officer now directly owns 435,811 shares in the company, valued at $23,119,773.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 15.73% of the company’s stock.

A number of analysts recently commented on WBA shares. Morgan Stanley set a $61.00 price objective on Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Tuesday, May 14th. SunTrust Banks increased their price objective on Walgreens Boots Alliance to $58.00 and gave the company a “hold” rating in a research note on Wednesday, April 3rd. Citigroup increased their price objective on J2 Global from $86.00 to $95.00 and gave the company a “neutral” rating in a research note on Wednesday, April 3rd. BidaskClub lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Monday, June 24th. Finally, JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of in a research note on Friday, June 28th. Six investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have given a buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Hold” and an average price target of $63.82.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: How to calculate compound interest

Dividend History for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply